NAV04/10/2024 Chg.-182.2500 Type de rendement Focus sur l'investissement Société de fonds
13,485.8301CZK -1.33% Full reinvestment Equity Sector Biotechnology Erste AM 
 

Objectif d'investissement

The ESPA STOCK BIOTEC fund invests in the most important biotech companies, primarily those in the USA. Equities from the Pacific region and Europe play a minor role, but are also selectively added to the fund. The currencies are not hedged against the euro. The fund is particularly suitable as an addition to an existing equity portfolio and is geared towards achieving long-term capital appreciation.
 

Opérations

Type de rendement: Full reinvestment
Fonds Catégorie: Equity
Pays: United States of America
Branche: Sector Biotechnology
Benchmark: Solactive United States Biotechnology Index NTR
Début de l'exercice: 15/03
Dernière distribution: 12/06/2014
Banque dépositaire: Erste Group Bank AG
Domicile: Austria
Permission de distribution: Austria, Germany, Czech Republic
Gestionnaire du fonds: Harald Kober, Tamas Menyhart
Actif net: 220.77 Mio.  EUR
Date de lancement: 19/12/2012
Focus de l'investissement: -

Conditions

Surtaxe d'émission: 4.00%
Frais d'administration max.: 1.80%
Investissement minimum: 0.00 CZK
Deposit fees: -
Frais de rachat: 0.00%
Prospectus simplifié: Télécharger (Version imprimée)
 

Société de fonds

Société de fonds: Erste AM
Adresse: Am Belvedere 1, 1100, Wien
Pays: Austria
Internet: www.erste-am.at
 

Actifs

Stocks
 
99.06%
Cash
 
0.94%

Pays

United States of America
 
79.99%
United Kingdom
 
9.60%
Netherlands
 
3.64%
China
 
1.08%
Bermuda
 
0.99%
Denmark
 
0.98%
Cash
 
0.94%
Canada
 
0.84%
Virgin Islands (British)
 
0.72%
Ireland
 
0.69%
Cayman Islands
 
0.27%
Belgium
 
0.16%
Spain
 
0.10%

Branches

Pharma/Biotechnology
 
95.61%
Healthcare services
 
3.45%
Cash
 
0.94%